Answers are grounded in this paper and cite their sources.
Coadministration of TDF with LPV/r resulted in increased tenofovir exposures at steady state, possibly through increased absorption. This increase is not believed to be clinically relevant based on the safety and efficacy of TDF plus LPV/r-containing regimens in HIV-infected patients in long-term controlled clinical trials.
No takes yet. Share an insight, caveat, or question.
Kearney et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: